Markg Martens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A phase 3 trial indicates the drug is safe and effective in treating acute and recurrent cases of acute vulvovaginal candidiasis, and preventing recurrence of VVC episodes.

United statesDrexel universityMarkg martensMycovia pharmaceuticalsDrexel university college of medicineDepartment of obstetricsDrexel university collegeDrug administrationDisease weekPresented septemberFungal infectionSkin and soft tissue infectionMedical conferencesProfessional societiesVaginal candidiasisVulvovaginal candidiasis